← All Signals

🏥 FDA: Wizcure Pharmaa Private Limited — Class II

healthcarebearishSource: FDA
95%Confidence
0Views
FDASource
2026-03-16Date

Summary

Another Wizcure sterility recall, this time for a lubricating eye gel distributed by hi-health, indicates the quality issues extend beyond HUB Pharmaceuticals. This raises red flags about Wizcure Pharmaa's entire manufacturing operation and its partners.

Actionable: Investigate any business relationships with Wizcure Pharmaa or hi-health for potential risk.

AI Confidence: 95%

Data Points

firmWizcure Pharmaa Private Limited
classificationClass II
statusOngoing
distributionDistributed Nationwide in the USA
productVista Gel Hypromellose USP 0.3% w/v, Eye Drops Dry Eye Relief Lubricating Gel, 10 ml. (1/3 fl. oz), Wizcure Pharmaa PVT. LTD, H-881, Phase-3, RIICO In

Get Signals Instantly

Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.

Subscribe Now